Cargando…

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy

Radiotherapy (RT) is a major modality of postoperative treatment in breast cancer. The maximal standardized value (SUVmax) is (18)FDG-PET/CT derived parameter that reported to be a valuable prognostic factor in cancer patients. Herein, we aimed to identify a prognostic gene signature associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Jin, Deshayes, Emmanuel, Zhang, Li, Shi, Wei, Zhang, Xiaomeng, Chen, Xingxing, Mei, Xin, Ma, Jinli, Jiang, Yizhou, Wu, Jiong, Shao, Zhimin, Yu, Xiaoli, Yang, Zhaozhi, Guo, Xiaomao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605077/ https://www.ncbi.nlm.nih.gov/pubmed/34853812 http://dx.doi.org/10.1016/j.omto.2021.10.008

Ejemplares similares

The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy
por: Wang, Xiaofang, et al.
Publicado: (2023)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China
por: Yang, Zhaozhi, et al.
Publicado: (2015)

Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype
por: Wang, Xiaofang, et al.
Publicado: (2018)

Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era
por: Ma, Jinli, et al.
Publicado: (2015)

Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)

CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020)

The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
por: Wei, Jinli, et al.
Publicado: (2020)

Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions
por: Shi, Wei, et al.
Publicado: (2023)

Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
por: Li, Chunyan, et al.
Publicado: (2021)

Estimating Cardiac Substructures Exposure From Diverse Radiotherapy Techniques in Treating Left-Sided Breast Cancer
por: Zhang, Li, et al.
Publicado: (2015)

Intensity modulated radiotherapy with fixed collimator jaws for locoregional left-sided breast cancer irradiation
por: Wang, Juanqi, et al.
Publicado: (2017)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients
por: Mao, Guangmin, et al.
Publicado: (2021)

HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
por: Hou, Jing, et al.
Publicado: (2016)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Prospective evaluation of skin toxicities in patients receiving post-mastectomy irradiation of chest wall, supra/infraclavicular and internal mammary nodes delivered by conventional versus intensity-modulated radiotherapy technique
por: Li, Juan, et al.
Publicado: (2017)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose
por: Hong, ZhengShan, et al.
Publicado: (2023)

Genomic Signature of the Standardized Uptake Value in (18)F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2020)

In-vivo Comparison of (18)F-FLT uptake, CT Number, Tumor Volume in Evaluation of Repopulation during Radiotherapy for Lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
por: Sepulcri, Matteo, et al.
Publicado: (2021)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Intratumoral (18)F-FLT infusion in metabolic targeted radiotherapy
por: Tippayamontri, Thititip, et al.
Publicado: (2019)

Technical feasibility of [(18)F]FET and [(18)F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
por: Verhoeven, Jeroen, et al.
Publicado: (2019)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

Predictive value of LN metastasis detected by (18)F-FDG PET/CT in patients with papillary thyroid cancer receiving iodine-131 radiotherapy
por: Li, Chao, et al.
Publicado: (2019)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

Identification of (18)F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
por: Galvez, Thierry, et al.
Publicado: (2023)

Comparison of [(18)F]FIMP, [(11)C]MET, and [(18)F]FDG PET for early-phase assessment of radiotherapy response
por: Nozaki, Satoshi, et al.
Publicado: (2023)

Prognostic value of metabolic tumor volume and total lesion glycolysis from (18)F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
por: Liu, Dou-dou, et al.
Publicado: (2019)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n6mlrphraa8b2fkf9tn17b2ub9